- The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory with descriptions and in quantities provided in the specifications.
- The number of days until which clarifications can be requested before the deadline for submitting offers is 18 days. The contracting authority will respond clearly and completely to all requests for clarifications on the 11th day before the deadline for submitting offers.

LOT-0001
Alpha-fetoprotein AFP.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0002
Carcinoembryonic antigen, CEA, rapid test.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0003
Prostate specific antigen.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0004
ASLO – latex, rapid tests.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0005
Lupus Cells - Latex for Lupus Erythematosus.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0006
Normal and pathological level control for PT, APTT, and fibrinogen.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0007
Rheumatoid factor, latex tests.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0008
HbsAg, rapid test.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0009
HCV, rapid test.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0010
Helicobacter Pylori, rapid test.
The framework agreement aims at concluding subsequent contracts for the purchase of necessary reagents for the Medical Analysis Laboratory. The descriptions and minimum and maximum quantities that are the subject of the framework agreement are presented in the specifications. The minimum and maximum quantities that could be the subject of a single subsequent contract as well as the estimated value of the largest subsequent contract expected to be concluded are detailed in the specifications. Subsequent contracts will be awarded monthly or quarterly, depending on the budget and the needs of the hospital. Subsequent contracts will be awarded without resuming competition among economic operators. The allocation of subsequent contracts to economic operators ranked 2nd and 3rd. In case the bidder ranked 1st declares that it does not have the capacity to fulfill the subsequent contract, the contracting authority will award the subsequent contract to the next economic operator ranked 2nd. The allocation of the subsequent contract to the operator ranked 3rd will occur if ranks 1 and 2 declare they do not have the capacity to fulfill the subsequent contract.

LOT-0011
RPR carbon.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0012
Urine strips, with 11 parameters.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0013
HIV tests, rapid test.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0014
Immunology tests for pregnancy diagnosis HCG, rapid test.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0015
Tests for detecting occult blood (FOB).
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0016
TPHA for syphilis confirmation.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0017
PCR kit – latex.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.

LOT-0018
Reagents compatible with the Coatron M1 analyzer.
The framework agreement aims to conclude successive contracts for the procurement of reagents necessary for the Medical Analysis Laboratory.
Description and minimum and maximum quantities subject to the framework agreement are presented in the specifications.
The minimum and maximum quantities that may be the subject of a single successive contract, as well as the estimated value of the largest successive contract expected to be concluded, are detailed in the specifications.
Successive contracts will be awarded monthly or quarterly, depending on the budget and the hospital's needs.
Successive contracts will be awarded without resuming competition between economic operators.
The awarding of successive contracts to economic operators ranked 2nd and 3rd. If the bidder ranked 1st declares that it is unable to fulfill the successive contract, the contracting authority will award the successive contract to the next economic operator ranked 2nd. The awarding of the successive contract to the operator ranked 3rd will occur if operators ranked 1 and 2 declare that they are unable to fulfill the successive contract.